Showing 2471-2480 of 4802 results for "".
Staphylococcus aureus Colonization
https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/In a recent review article, Piewngam and Otto examined the epidemiology, mechanisms, and clinical implications of Staphylococcus aureus (S. aureus) colonization, while evaluating both current and emerging strategies for decolonization.Hidradenitis Suppurativa: Focus on Diagnosis
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-focus-on-diagnosis/23816/An expert discusses unmet needs in identifying and treating this inflammatory disease.The Clinical Significance of Gene Expression Profile Testing for Melanoma
https://practicaldermatology.com/topics/practice-management/the-clinical-significance-of-gene-expression-profile-testing-for-melanoma/20647/Accumulated evidence on GEP Classification suggests that it provides clinically relevant information that can influence patient management for the better.New Products/Therapeutics Focus: Devices
https://practicaldermatology.com/columns/new-products/new-productstherapeutics-focus-devices/20690/Prevention Efforts: Where We Stand
https://practicaldermatology.com/topics/practice-management/prevention-efforts-where-we-stand/21149/The Price of a Penalty: Unraveling CMS's Latest Moves
https://practicaldermatology.com/topics/practice-management/the-price-of-a-penalty-unraveling-cmss-latest-moves/21435/State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.Cutaneous Manifestations Associated with Nemolizumab
https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/In the 2025 study by Sasaki et al entitled “Clinical characteristics and risk factors for cutaneous manifestations associated with nemolizumab in atopic dermatitis: a multicenter retrospective study in Japan,” nemolizumab-induced cutaneous eruptions were found to be relatively common, typically occuReflections On a Year Unlike Any Other
https://practicaldermatology.com/topics/practice-management/reflections-on-a-year-unlike-any-other/23398/Change is good and other hard lessons from 2020.DEF Announces First Mentorship Grant Awardee
https://practicaldermatology.com/topics/general-topics/def-announces-first-mentorship-grant-awardee/23014/Grant awards are intended to enhance the best practices necessary to recognize the skin diseases and conditions pertinent in dermatologic practice.